The results of relevant clinical pathological parameters analyses showed that MALAT-1 expression related to the gender, tumor size, LNM, tumor differentiation and TNM stage, disclosed that poor tumor differentiation, advanced stage, increased tumor diameter, and LNM are all risk factors for poor prognosis of NSCLC. The gene discussed is MALAT1; the disease is neoplasm.